(Circulation. 2000;101:1552.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Hospital of the Westfälische Wilhelms-University, Department of Cardiology and Angiology and Institute for Arteriosclerosis Research (T.W., M.B., G.B.) and Department of Nuclear Medicine (MS, H.L., O.S.), Münster, Germany, and the Medical Research Council-Cyclotron Unit and Imperial College School of Medicine, Hammersmith Hospital (C.G.R., A.A.L, F.H., P.G.C.), London, UK.
Correspondence to Dr Thomas Wichter, Medizinische Klinik und Poliklinik, Innere Medizin C (Kardiologie und Angiologie), Westfälische Wilhelms Universität, D-48129 Münster, Germany. E-mail wichtet{at}uni-muenster.de
BackgroundThe frequent provocation of ventricular tachycardia by stress or catecholamines and the efficacy of antiarrhythmic drugs with antiadrenergic properties suggest an involvement of the cardiac adrenergic system in arrhythmogenesis in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). Previous studies demonstrated abnormalities of the presynaptic uptake-1 assessed by 123I-MIBGsingle-photon emission computed tomography.
Methods and ResultsThis study investigated neuronal reuptake of norepinephrine (uptake-1) and ß-adrenergic receptor density in 8 patients with ARVC and 29 age-matched control subjects. All subjects underwent positron emission tomography with the volume of distribution (Vd) of [11C]hydroxyephedrine (11C-HED) used to assess presynaptic norepinephrine reuptake, the maximum binding capacity (Bmax) of [11C]CGP-12177 (11C-CGP-12177) to assess postsynaptic ß-adrenergic receptor density, and [15O]H2O for quantification of myocardial blood flow. Patients with ARVC demonstrated a highly significant global reduction in postsynaptic ß-adrenergic receptor density compared with that in control subjects (Bmax of 11C-CGP-12177: 5.9±1.3 vs 10.2±2.9 pmol/g tissue, P<0.0007), whereas the presynaptic uptake-1 tended toward reduction only (Vd of 11C-HED: 59.1±25.2 vs 71.0±18.8 mL/g tissue, NS). There were no differences in myocardial blood flow between the groups, and plasma norepinephrine was within normal limits in patients and control subjects.
ConclusionsThe findings demonstrate a significant reduction of myocardial ß-adrenergic receptor density in patients with ARVC. This may result from a secondary downregulation after increased local synaptic norepinephrine levels caused by increased firing rates of the efferent neurons or as the result of impaired presynaptic catecholamine reuptake. These findings give new insights into the pathophysiology of arrhythmogenesis in ARVC, with potential impact on diagnostic evaluation and therapeutic management.
Key Words: cardiomyopathy ventricular tachycardia nervous system, autonomic receptors, adrenergic, beta tomography
This article has been cited by other articles:
![]() |
P. Cabrales, A. G. Tsai, and M. Intaglietta Modulation of Perfusion and Oxygenation by Red Blood Cell Oxygen Affinity during Acute Anemia Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 354 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Caldwell, J. M. Link, W. C. Levy, J. E. Poole, and J. R. Stratton Evidence for Pre- to Postsynaptic Mismatch of the Cardiac Sympathetic Nervous System in Ischemic Congestive Heart Failure J. Nucl. Med., February 1, 2008; 49(2): 234 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cabrales, B. Y. S. Vazquez, A. G. Tsai, and M. Intaglietta Microvascular and capillary perfusion following glycocalyx degradation J Appl Physiol, June 1, 2007; 102(6): 2251 - 2259. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kies, T. Wichter, M. Schafers, M. Paul, K. P. Schafers, L. Eckardt, L. Stegger, E. Schulze-Bahr, O. Rimoldi, G. Breithardt, et al. Abnormal Myocardial Presynaptic Norepinephrine Recycling in Patients With Brugada Syndrome Circulation, November 9, 2004; 110(19): 3017 - 3022. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mardon, O. Montagne, N. Elbaz, Z. Malek, A. Syrota, J.-L. Dubois-Rande, M. Meignan, and P. Merlet Uptake-1 Carrier Downregulates in Parallel with the {beta}-Adrenergic Receptor Desensitization in Rat Hearts Chronically Exposed to High Levels of Circulating Norepinephrine: Implications for Cardiac Neuroimaging in Human Cardiomyopathies J. Nucl. Med., September 1, 2003; 44(9): 1459 - 1466. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Furuhashi, K. Uno, K. Tsuchihashi, T. Wichter, P. Matheja, L. Eckardt, P. Kies, K. Schafers, E. Schulze-Bahr, W. Haverkamp, et al. Myocardial Iodine-123-Metaiodobenzylguanidine (123I-MIBG) Imaging in Brugada Syndrome * Response Circulation, September 24, 2002; 106 (13): e59 - e60. [Full Text] [PDF] |
||||
![]() |
M. Pissarek, J. Ermert, G. Oesterreich, D. Bier, and H. H. Coenen Relative Uptake, Metabolism, and {beta}-Receptor Binding of (1R,2S)-4-18F-Fluorometaraminol and 123I-MIBG in Normotensive and Spontaneously Hypertensive Rats J. Nucl. Med., March 1, 2002; 43(3): 366 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wichter, P. Matheja, L. Eckardt, P. Kies, K. Schafers, E. Schulze-Bahr, W. Haverkamp, M. Borggrefe, O. Schober, G. Breithardt, et al. Cardiac Autonomic Dysfunction in Brugada Syndrome Circulation, February 12, 2002; 105(6): 702 - 706. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |